FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Silvio Rea

Research Profile

Procedures

Chemicals & Drugs

Concepts & Ideas

Disorders

Anatomy

Killer Cells, Natural

Co-author Network

Publications

TOP 3
Francesco Recchia; Cornelia O C Recchia; Giampiero Candeloro; Vincenzo Cirulli; Giovambattista Desideri; Stefano Necozione; Silvio Rea
Triple-negative breast cancer: multipronged approach, single-arm pilot phase II study.
Francesco Recchia; Pietro Boscarato; Giampiero Candeloro; Giovambattista Desideri; Marco Doddi; Pietro Filauri; Stefano Necozione; Giovanni Passalacqua; Silvio Rea
Chemoembolization of unresectable hepatocellular carcinoma: Decreased toxicity with slow-release doxorubicin‑eluting beads compared with lipiodol.
Francesco Recchia; Gigliola Sica; Giampiero Candeloro; Roberta Bisegna; Massimo Bratta; Pierluigi Bonfili; Stefano Necozione; Vincenzo Tombolini; Silvio Rea
Chemoradioimmunotherapy in locally advanced pancreatic and biliary tree adenocarcinoma: a multicenter phase II study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Silvio Rea (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Francesco Recchia; Cornelia O C Recchia; Giampiero Candeloro; Vincenzo Cirulli; Giovambattista Desideri; Stefano Necozione; Silvio Rea
Triple-negative breast cancer: multipronged approach, single-arm pilot phase II study.
Cancer medicine 2012;1(1):89-95.
2012: Francesco Recchia; Pietro Boscarato; Giampiero Candeloro; Giovambattista Desideri; Marco Doddi; Pietro Filauri; Stefano Necozione; Giovanni Passalacqua; Silvio Rea
Chemoembolization of unresectable hepatocellular carcinoma: Decreased toxicity with slow-release doxorubicin‑eluting beads compared with lipiodol.
Oncology reports 2012;27(5):1377-83.
2009: Francesco Recchia; Gigliola Sica; Giampiero Candeloro; Roberta Bisegna; Massimo Bratta; Pierluigi Bonfili; Stefano Necozione; Vincenzo Tombolini; Silvio Rea
Chemoradioimmunotherapy in locally advanced pancreatic and biliary tree adenocarcinoma: a multicenter phase II study.
Pancreas 2009;38(6):e163-8.
2009: Francesco Recchia; Gigliola Sica; Giampiero Candeloro; Stefano Necozione; Roberta Bisegna; Massimo Bratta; Silvio Rea
Beta-interferon, retinoids and tamoxifen in metastatic breast cancer: long-term follow-up of a phase II study.
Oncology reports 2009;21(4):1011-6.
2009: Francesco Recchia; Giampiero Candeloro; Stefano Necozione; Roberta Bisegna; Massimo Bratta; Silvio Rea
Immunotherapy in patients with less than complete response to chemotherapy.
Anticancer research 2009;29(2):567-72.
2008: Francesco Recchia; Gigliola Sica; Giampiero Candeloro; Stefano Necozione; Roberta Bisegna; Massimo Bratta; Silvio Rea
Maintenance immunotherapy in metastatic breast cancer.
Oncology reports 2008;20(5):1173-9.
2008: Francesco Recchia; Giampiero Candeloro; Stefano Necozione; Massimo Bratta; Roberta Bisegna; Silvio Rea
Alternating XELFOX and XELFIRI in patients with metastatic colorectal cancer.
American journal of clinical oncology 2008;31(4):323-8.
2008: Francesco Recchia; Giampiero Candeloro; Mario Di Staso; Stefano Necozione; Roberta Bisegna; Massimo Bratta; Vincenzo Tombolini; Silvio Rea
Maintenance immunotherapy in recurrent or metastatic squamous cell carcinoma of the head and neck.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2008;31(4):413-9.
2008: Francesco Recchia; Giampiero Candeloro; Stefano Necozione; Luca Fumagalli; Massimo Bratta; Silvio Rea
Multicenter phase II study of chemoimmunotherapy in the treatment of metastatic melanoma.
Anti-cancer drugs 2008;19(2):201-7.
2007: Francesco Recchia; Gaetano Saggio; Giovanna Amiconi; Anna Di Blasio; Alisia Cesta; Giampiero Candeloro; Gaspare Carta; Stefano Necozione; Giovanni Mantovani; Silvio Rea
A multicenter phase II study of pegylated liposomal doxorubicin and oxaliplatin in recurrent ovarian cancer.
Gynecologic oncology 2007;106(1):164-9.
2007: Francesco Recchia; Gaetano Saggio; Giampiero Candeloro; Alisia Cesta; Giovanna Amiconi; Anna Di Blasio; Stefano Necozione; Silvio Rea
Chemoimmunotherapy in the treatment of metastatic gastric cancer.
Anti-cancer drugs 2007;18(5):597-604.
2007: Francesco Recchia; Gaetano Saggio; Giovanna Amiconi; Anna Di Blasio; Alisia Cesta; Giampiero Candeloro; Stefano Necozione; Luca Fumagalli; Silvio Rea
Multicenter phase II study of chemo-immunotherapy in the treatment of metastatic renal cell carcinoma.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2007;30(4):448-54.
2007: Francesco Recchia; Gaetano Saggio; Alisia Cesta; Giampiero Candeloro; Anna Di Blasio; Giovanna Amiconi; Marco Lombardo; Antonio Nuzzo; Angelo Lalli; Edoardo Alesse; Stefano Necozione; Silvio Rea
Phase II study of interleukin-2 and 13-cis-retinoic acid as maintenance therapy in metastatic colorectal cancer.
Cancer immunology, immunotherapy : CII 2007;56(5):699-708.
2006: Francesco Recchia; Gaetano Saggio; Alisia Cesta; Giovanna Amiconi; Anna Di Blasio; Giampiero Candeloro; Maurizio Valeriani; Vincenzo Tombolini; Silvio Rea
Dose-finding study of docetaxel added to ifosfamide and cisplatin followed by concomitant capecitabine and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
Anticancer research 2006;26(3B):2317-24.
2006: Francesco Recchia; Gaetano Saggio; Giovanna Amiconi; Anna Di Blasio; Alisia Cesta; Giampiero Candeloro; Silvio Rea
Gonadotropin-releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma.
Cancer 2006;106(3):514-23.
2006: Francesco Recchia; Gaetano Saggio; Giovanna Amiconi; Anna Di Blasio; Alisia Cesta; Giampiero Candeloro; Silvio Rea; Gianantonio Nappi
Cardiac metastases in malignant fibrous histiocytoma. A case report.
Tumori 2006;92(1):76-8.
2006: Francesco Recchia; Gaetano Saggio; Antonio Nuzzo; Edoardo Biondi; Anna Di Blasio; Alisia Cesta; Giampiero Candeloro; Edoardo Alesse; Silvio Rea
Multicenter phase 2 study of interleukin-2 and 13-cis retinoic acid as maintenance therapy in advanced non-small-cell lung cancer.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2006;29(1):87-94.
2005: Francesco Recchia; Gaetano Saggio; Alisia Cesta; Giampiero Candeloro; Antonio Nuzzo; Marco Lombardo; Gaspare Carta; Silvio Rea
Interleukin-2 and 13-cis retinoic acid as maintenance therapy in advanced ovarian cancer.
International journal of oncology 2005;27(4):1039-46.
2005: Francesco Recchia; Gaetano Saggio; Alisia Cesta; Edoardo Alesse; Rita Gallo; Stefano Necozione; Silvio Rea
Phase II randomized study of interleukin-2 with or without 13-cis retinoic acid as maintenance therapy in patients with advanced cancer responsive to chemotherapy.
Anticancer research 2005;25(4):3149-57.
2005: Francesco Recchia; Gaetano Saggio; Alisia Cesta; Giampiero Candeloro; Silvio Rea
Paclitaxel plus gemcitabine in advanced non-small cell lung cancer patients with low performance status.
Anticancer research 2005;25(1B):409-14.
2004: Francesco Recchia; Gaetano Saggio; Antonio Nuzzo; Angelo Lalli; L Di Lullo; Alisia Cesta; Silvio Rea
Multicentre phase II study of bifractionated CPT-11 with bimonthly leucovorin and 5-fluorouracil in patients with metastatic colorectal cancer pretreated with FOLFOX.
British journal of cancer 2004;91(8):1442-6.
2004: Francesco Recchia; Silvio Rea; Antonio Nuzzo; Angelo Lalli; Liberato Di Lullo; Sandro De Filippis; Gaetano Saggio; Edoardo Biondi; Elena Massa; Giovanni Mantovani
Oxaliplatin fractionated over two days with bimonthly leucovorin and 5-fluorouracil in metastatic colorectal cancer.
Anticancer research 2004;24(3b):1935-40.
2003: Francesco Recchia; Alisia Cesta; Silvio Rea
Low dose interleukin-2 and 13-cis-retinoic acid as maintenance therapy in patients with solid tumors responsive to chemotherapy.
Journal of experimental & clinical cancer research : CR 2003;22(4 Suppl):135-43.
2003: Francesco Recchia; Sandro De Fillipis; Massimo Piccinini; Silvio Rea
High-dose carboplatin, cyclophosphamide, etoposide with hematological growth factors, without stem cell support in patients with advanced cancer.
Anticancer research 2003;23(5b):4141-7.
2003: Francesco Recchia; Sandro De Filippis; Gaetano Saggio; Giovanna Amiconi; Alisia Cesta; Gaspare Carta; Silvio Rea
Phase I study of liposomal doxorubicin and oxaliplatin as salvage chemotherapy in advanced ovarian cancer.
Anti-cancer drugs 2003;14(8):633-8.
2003: Francesco Recchia; Antonio Nuzzo; Angelo Lalli; Liberato Di Lullo; Sandro De Filippis; Gaetano Saggio; Anna Di Blasio; Silvio Rea
Multicenter phase II study of CPT-11 fractionated over two days with bimonthly leucovorin and 5-fluorouracil in patients with metastatic colorectal cancer.
Anticancer research 2003;23(3C):2903-8.
2003: Francesco Recchia; Silvio Rea; Antonio Nuzzo; Angelo Lalli; Liberato Di Lullo; Sandro De Filippis; Gaetano Saggio; Anna Di Blasio; E Massa; Giovanni Mantovani
Multicenter phase II study of fractionated bimonthly oxaliplatin with leucovorin and 5-fluorouracil in patients with metastatic colorectal cancer, pre-treated with chemotherapy.
Oncology reports 2003;10(1):65-9.
2002: Francesco Recchia; Sandro De Filippis; Michele Rosselli; Gaetano Saggio; Luca Fumagalli; Silvio Rea
Interleukin-2 and 13-cis retinoic acid in the treatment of minimal residual disease: a phase II study.
International journal of oncology 2002;20(6):1275-82.
2002: Francesco Recchia; Gigliola Sica; Sandro De Filippis; Gaetano Saggio; Michele Rosselli; Silvio Rea
Goserelin as ovarian protection in the adjuvant treatment of premenopausal breast cancer: a phase II pilot study.
Anti-cancer drugs 2002;13(4):417-24.
2002: Francesco Recchia; Marco Lombardo; Sandro De Filippis; Michele Rosselli; Silvio Rea
Gemcitabine, ifosfamide and vinorelbine in advanced non-small cell lung cancer: a phase II study.
Anticancer research 2002;22(2B):1321-8.
2001: Francesco Recchia; Sandro De Filippis; Michele Rosselli; Gaetano Saggio; Massimo Piccinini; Silvio Rea
5-fluorouracil-carboplatin continuous infusion as salvage chemotherapy in advanced cancer.
Tumori 2001;87(6):383-7.
2001: Francesco Recchia; Angelo Lalli; Marco Lombardo; Sandro De Filippis; Gaetano Saggio; F Fabbri; Michele Rosselli; E Capomolla; Silvio Rea
Ifosfamide, cisplatin, and 13-Cis retinoic acid for patients with advanced or recurrent squamous cell carcinoma of the head and neck: a phase I-II study.
Cancer 2001;92(4):814-21.
2001: Francesco Recchia; Sandro De Filippis; Michele Rosselli; Gaetano Saggio; PL Pompili; Massimo Piccinini; Silvio Rea
Combined 5-fluorouracil infusion with fractionated epirubicin and cyclophosphamide in advanced breast cancer.
American journal of clinical oncology 2001;24(4):392-6.
2001: Francesco Recchia; Gigliola Sica; Sandro De Filippis; Michele Rosselli; PL Pompili; Silvio Rea
Phase II study of epirubicin, mitomycin C, and 5-fluorouracil in hormone-refractory prostatic carcinoma.
American journal of clinical oncology 2001;24(3):232-6.
2001: Francesco Recchia; Sandro De Filippis; Michele Rosselli; Gaetano Saggio; Alisia Cesta; Luca Fumagalli; Silvio Rea
Phase 1B study of subcutaneously administered interleukin 2 in combination with 13-cis retinoic acid as maintenance therapy in advanced cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(5):1251-7.
2001: Francesco Recchia; Sandro De Filippis; Michele Rosselli; Gaetano Saggio; Gaspare Carta; Silvio Rea
Primary chemotherapy in stage IV ovarian cancer. A prospective phase II study.
European journal of gynaecological oncology 2001;22(4):287-91.
2000: Francesco Recchia; Gigliola Sica; Sandro De Filippis; Michele Rosselli; Gaetano Saggio; G Guerriero; PL Pompili; Silvio Rea
Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study.
Anticancer research 2000;20(3B):1985-90.
2000: Francesco Recchia; Patrizia Accorsi; Tiziana Bonfini; Sandro De Filippis; M Grimaldi; G Corrao; Michele Rosselli; Giovanna Amiconi; Antonio Iacone; Silvio Rea
Randomized trial of sequential administration of G-CSF and GM-CSF vs. G-CSF alone following peripheral blood progenitor cell autograft in solid tumors.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2000;20(2):171-7.
1999: Francesco Recchia; Sandro De Filippis; Michele Rosselli; PL Pompili; G Guerriero; Silvio Rea
Ifosfamide, vinorelbine and gemcitabine in advanced non-small cell lung cancer. A phase I study.
European journal of cancer (Oxford, England : 1990) 1999;35(10):1457-61.
1999: Francesco Recchia; Sandro De Filippis; PL Pompili; Michele Rosselli; Gaetano Saggio; A Ciorra; Massimo Piccinini; Silvio Rea
Carboplatin, vindesine, 5-fluorouracil-leucovorin and 13-cis retinoic acid in the treatment of advanced non-small cell lung cancer. A phase II study.
La Clinica terapeutica 1999;150(4):269-74.
1999: Francesco Recchia; A Lococo; Costantino Campisi; Angelo Lalli; Liberato Di Lullo; Sandro De Filippis; Maurizio Vaccarili; A Zappalà; G Corrao; Silvio Rea
Carboplatin, ifosfamide, and vinorelbine in the treatment of advanced non-small-cell lung cancer: a phase II study.
American journal of clinical oncology 1999;22(1):57-61.
1999: Francesco Recchia; Gigliola Sica; Sandro De Filippis; Michele Rosselli; PL Pompili; Gaetano Saggio; Silvio Rea
Chemo-immunotherapy in advanced head and neck cancer.
Anticancer research 1999;19(1B):773-7.
1998: Francesco Recchia; Silvio Rea; Sandro De Filippis; Michele Rosselli; G Corrao; A Gulino; Gigliola Sica
Beta-interferon, retinoids and tamoxifen combination in advanced breast cancer.
La Clinica terapeutica 1998;149(3):203-8.
1998: Francesco Recchia; L Frati; Silvio Rea; P Torchio; G Sica
Minimal residual disease in metastatic breast cancer: treatment with IFN-beta, retinoids, and tamoxifen.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1998;18(1):41-7.
1997: Francesco Recchia; Gigliola Sica; Sandro De Filippis; Silvio Rea; L Frati
Combined chemotherapy and differentiation therapy in the treatment of advanced non-small-cell lung cancer.
Anticancer research 1997;17(5B):3761-5.
1997: Francesco Recchia; Sandro De Filippis; Lia Ginaldi; D Quaglino; A Gulino; L Frati; Silvio Rea
Phase I-II study of dose intensified chemotherapy with filgrastim and thymopentin in patients with advanced cancer.
La Clinica terapeutica 1997;148(5-6):201-7.
1997: Francesco Recchia; Sandro De Filippis; P Torchio; Silvio Rea; A Gulino; D Quaglino; L Frati
Randomized trial of filgrastim vs. sequential filgrastim and molgramostim after dose-intensified carboplatin, cyclophosphamide, and etoposide: a phase I pilot study.
American journal of clinical oncology 1997;20(2):209-14.
1995: Francesco Recchia; Silvio Rea; PL Pompili; D Casucci; M J Rea; F Rizzo; A Gulino; Luigi Frati
Beta-interferon, retinoids and tamoxifen as maintenance therapy in metastatic breast cancer. A pilot study.
La Clinica terapeutica 1995;146(10):603-10.
1995: Francesco Recchia; Silvio Rea; G Corrao; A Fingerhut; Luigi Frati
Sequential chemotherapy, beta interferon, retinoids and tamoxifen in the treatment of metastatic breast cancer. A pilot study.
European journal of cancer (Oxford, England : 1990) 1995;31A(11):1887-8.
1995: Francesco Recchia; G Sica; Sandro De Filippis; S Discepoli; Silvio Rea; P Torchio; Luigi Frati
Interferon-beta, retinoids, and tamoxifen in the treatment of metastatic breast cancer: a phase II study.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1995;15(7):605-10.
1995: Francesco Recchia; G Passalacqua; Sandro De Filippis; P Filauri; P Lippe; Silvio Rea; A Fingerhut; Luigi Frati
[Role of polychemoembolization in the treatment of primary and secondary tumors of the liver].
La Clinica terapeutica 1995;146(2):117-22.
1993: Francesco Recchia; S Lelli; G Di Matteo; Silvio Rea; Luigi Frati
[5-fluorouracil, cisplatin and retinol palmitate in the management of advanced cancer of the oral cavity. Phase II study].
La Clinica terapeutica 1993;142(5):403-9.
1992: Silvio Rea; Francesco Recchia; L Belli; Marie-Lise Jaffrain-Rea; Luigi Frati
[Does an efficacious adjuvant treatment exist in resected colonic carcinoma?].
La Clinica terapeutica 1992;140(4):323-30.
1991: Silvio Rea; Francesco Recchia; L Belli; Marie-Lise Jaffrain-Rea
[Prevention of hepatic metastases in radically operated colonic cancers].
Annales de chirurgie 1991;45(4):306-12.